GW873140 In Combination With Combivir In HIV Infected Subjects

PHASE2TerminatedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Infection, Human Immunodeficiency Virus IHIV Infection
Interventions
DRUG

GW873140

DRUG

Combivir

Trial Locations (51)

1000

GSK Investigational Site, Brussels

7102

GSK Investigational Site, Newark

10008

GSK Investigational Site, New York

14604

GSK Investigational Site, Rochester

19107

GSK Investigational Site, Philadelphia

20009

GSK Investigational Site, Washington D.C.

20127

GSK Investigational Site, Milan

20157

GSK Investigational Site, Milan

25125

GSK Investigational Site, Brescia

28029

GSK Investigational Site, Madrid

30013

GSK Investigational Site, Conyers

30342

GSK Investigational Site, Tarzana

30625

GSK Investigational Site, Hanover

32804

GSK Investigational Site, Orlando

32960

GSK Investigational Site, Vero Beach

33136

GSK Investigational Site, Miami

33607

GSK Investigational Site, Tampa

44093

GSK Investigational Site, Nantes

55404

GSK Investigational Site, Minneapolis

60590

GSK Investigational Site, Frankfurt am Main

60612

GSK Investigational Site, Chicago

69288

GSK Investigational Site, Lyon

75018

GSK Investigational Site, Paris

75208

GSK Investigational Site, Dallas

75215

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

80205

GSK Investigational Site, Denver

89102

GSK Investigational Site, Las Vegas

90022

GSK Investigational Site, Los Angeles

90095

GSK Investigational Site, Los Angeles

90210

GSK Investigational Site, Beverly Hills

92300

GSK Investigational Site, Levallois-Perret

93301

GSK Investigational Site, Bakersfield

94114

GSK Investigational Site, San Francisco

94305

GSK Investigational Site, Stanford

97080

GSK Investigational Site, Würzburg

97210

GSK Investigational Site, Portland

02114

GSK Investigational Site, Boston

02908

GSK Investigational Site, Providence

K1N 6N5

GSK Investigational Site, Ottawa

M4N 3M5

GSK Investigational Site, Toronto

H2L 4P9

GSK Investigational Site, Montreal

H2L 5B1

GSK Investigational Site, Montreal

3000-075

GSK Investigational Site, Coimbra

1169-100

GSK Investigational Site, Lisbon

4200-319

GSK Investigational Site, Porto

M8 5RB

GSK Investigational Site, Manchester

BN2 1ES

GSK Investigational Site, Brighton

B29 6JD

GSK Investigational Site, Birmingham

EC1 7BE

GSK Investigational Site, London

SW10 9TH

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ViiV Healthcare

INDUSTRY